- Q3 2024 BioArctic AB Earnings Call(Q&A-session) TranscriptNov 14, 2024€12.96 (+7.55%)Earnings
- Q1 2024 BioArctic AB Earnings Call TranscriptMay 17, 2024€19.79 (-1.44%)Earnings
- Q4 2023 BioArctic AB Earnings Call TranscriptFeb 14, 2024€19.25 (+2.39%)Earnings
- Q3 2023 BioArctic AB Earnings Call TranscriptNov 08, 2023€18 (+0.28%)Earnings
- Q2 2023 BioArctic AB Earnings Call TranscriptJul 12, 2023€24.5 (-2.93%)Earnings
- Q1 2023 BioArctic AB Earnings Call TranscriptApr 27, 2023€22.18 (+8.83%)Earnings
- Q4 2022 BioArctic AB Earnings Call TranscriptFeb 03, 2023€25.98 (-1.44%)Earnings
- Q3 2022 BioArctic AB Earnings Call TranscriptOct 20, 2022€22.26 (-3.13%)Earnings
- Q2 2022 BioArctic AB Earnings Call TranscriptJul 12, 2022€7.27 (-1.96%)Earnings
- Q1 2022 BioArctic AB Earnings Call TranscriptApr 28, 2022€7.27 (-3.00%)Earnings
- Q4 2021 BioArctic AB Earnings Call TranscriptFeb 03, 2022€10.4 (+0.39%)Earnings
- Q3 2021 BioArctic AB Earnings Call TranscriptOct 21, 2021€14.5 (+2.26%)Earnings
- Q2 2021 BioArctic AB Earnings Call TranscriptJul 09, 2021€14.02 (-1.54%)Earnings
- Q1 2021 BioArctic AB Earnings Call TranscriptApr 21, 2021€8.79 (-2.55%)Earnings
- Full Year 2020 BioArctic AB Earnings Call TranscriptFeb 04, 2021€9.84 (+0.51%)Earnings
- Nine Months 2020 BioArctic AB Earnings Call TranscriptOct 14, 2020€8.31 (+0.12%)Earnings
- Q2 2020 BioArctic AB Earnings Call TranscriptJul 10, 2020€7.07 (-1.74%)Earnings
- Q1 2020 BioArctic AB Earnings Call TranscriptApr 22, 2020€5.99 (-7.99%)Earnings
- Full Year 2019 BioArctic AB Earnings Call TranscriptFeb 06, 2020€8 (-0.37%)Earnings
- Q3 2019 BioArctic AB Earnings Call TranscriptOct 24, 2019€8.29 (-1.31%)Earnings
- Q2 2019 BioArctic AB Earnings Call TranscriptJul 11, 2019€6.7 (-0.89%)Earnings
- Q1 2019 BioArctic AB Earnings Call TranscriptMay 09, 2019€6.88 (+2.23%)Earnings
- Full Year 2018 BioArctic AB Earnings Call TranscriptFeb 14, 2019€9.01 (+0.45%)Earnings
Q4 2021 BioArctic AB Earnings Call Transcript
Hello, and welcome to the BioArctic Audiocast for Teleconference Q4 2021. (Operator Instructions) Just to remind you, this conference call is being recorded.
Today, I am pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. Please go ahead with your meeting.
()-
Thank you, and good morning, and welcome to BioArctic's full year report for 2021. I will also give some highlights from the fourth quarter. I'm Gunilla Osswald, and I'm the CEO of BioArtic, and I will share today's presentation with our CFO, Jan Mattsson.
It has been a great year for BioArctic and lecanemab, and it is time of hope for Alzheimer's patients. Lecanemab got fast track and breakthrough therapy designation by the FDA during the last year. And our partner Eisai has had interactions with the FDA. And after that, they have initiated a rolling submission, which is ongoing for an accelerated approval for lecanemab in the U.S.
I think that this year will be the most exciting year for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)